- Home
- TIGR vs IRON Comparison
TIGR vs IRON Comparison
Compare TIGR & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIGR
- IRON
- Stock Information
- Founded
- TIGR 2014
- IRON 2017
- Country
- TIGR Singapore
- IRON United States
- Employees
- TIGR N/A
- IRON N/A
- Industry
- TIGR Investment Bankers/Brokers/Service
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- TIGR Finance
- IRON Health Care
- Exchange
- TIGR Nasdaq
- IRON Nasdaq
- Market Cap
- TIGR 2.3B
- IRON 2.0B
- IPO Year
- TIGR 2019
- IRON N/A
- Fundamental
- Price
- TIGR $12.72
- IRON $60.19
- Analyst Decision
- TIGR Strong Buy
- IRON Strong Buy
- Analyst Count
- TIGR 2
- IRON 10
- Target Price
- TIGR $10.79
- IRON $97.80
- AVG Volume (30 Days)
- TIGR 6.4M
- IRON 307.4K
- Earning Date
- TIGR 08-27-2025
- IRON 08-07-2025
- Dividend Yield
- TIGR N/A
- IRON N/A
- EPS Growth
- TIGR 305.45
- IRON N/A
- EPS
- TIGR 0.66
- IRON N/A
- Revenue
- TIGR $421,673,984.00
- IRON N/A
- Revenue This Year
- TIGR $53.82
- IRON N/A
- Revenue Next Year
- TIGR $13.18
- IRON N/A
- P/E Ratio
- TIGR $19.78
- IRON N/A
- Revenue Growth
- TIGR 68.66
- IRON N/A
- 52 Week Low
- TIGR $3.39
- IRON $30.82
- 52 Week High
- TIGR $14.48
- IRON $68.73
- Technical
- Relative Strength Index (RSI)
- TIGR 61.88
- IRON 53.89
- Support Level
- TIGR $11.83
- IRON $58.87
- Resistance Level
- TIGR $13.02
- IRON $63.51
- Average True Range (ATR)
- TIGR 0.76
- IRON 2.04
- MACD
- TIGR 0.12
- IRON 0.00
- Stochastic Oscillator
- TIGR 76.49
- IRON 36.35
About TIGR UP Fintech Holding Ltd representing fifteen
UP Fintech Holding Ltd is an online brokerage firm focusing on Chinese investors. Its trading platform enables investors to trade in equities and other financial instruments on multiple exchanges of stocks and other derivatives. The company offers its customers brokerage and value-added services, including trade order placement and execution, margin financing, account management, investor education, community discussion, and customer support.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.